Experience and challenges from clinical trials with malaria vaccines in Africa - Wikidata - wikimedia - TriplyDB

Experience and challenges from clinical trials with malaria vaccines in Africa

Experience and challenges from clinical trials with malaria vaccines in Africa

http://www.wikidata.org/entity/Q36690983

about

Surveillance-response systems: the key to elimination of tropical diseases Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews Good and Bad Research Collaborations: Researchers' Views on Science and Ethics in Global Health Research Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature.Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements.Hematological and biochemical data obtained in rural northern Uganda.Early phase clinical trials with human immunodeficiency virus-1 and malaria vectored vaccines in The Gambia: frontline challenges in study design and implementation.TB Vaccines: The (Human) Challenge Ahead.Health providers' perceptions of clinical trials: lessons from Ghana, Kenya and Burkina Faso.Symphysiotomy for obstructed labour: a systematic review and meta-analysis."You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa.The Ethics of Health Care Delivery in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania.Good collaborative practice: reforming capacity building governance of international health research partnerships.Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study.

P2860

Q24288903-C0D1CE14-3A87-4CF2-9E54-886C7047A8B8 Q26783200-15F2BCF9-40E5-404B-8F36-33CD4D3EB588 Q28597619-866BBEB3-B28B-4CAC-8B64-3C42CBC70822 Q30378952-629BF93A-80DA-4FC4-B68A-16694F2525F1 Q30565638-1C6BBB75-4F77-453E-9D99-8925F7E6F2A1 Q30815803-8497C02A-F009-4CFC-8AD7-7F7739C18C41 Q33588543-925C6B52-188F-4C74-A09E-39EA4E681F5A Q34676075-97CC15B2-7061-40BA-91BB-391BA90A071C Q35560610-0D9931CB-0A53-4A22-A391-206BF6DF2F0B Q36002570-8D693008-5144-4019-B116-E093184EE504 Q36310614-20A93A10-29C3-4A71-BA36-373E0AD126E7 Q46190745-28B810E3-6F02-437D-B3B7-84D6E96F128D Q47274966-31AEF42E-1247-470F-BB20-6754AEBB9853 Q53711068-9F118377-BFC8-4027-80CC-B37CF2351D7E

P2860

Experience and challenges from clinical trials with malaria vaccines in Africa

http://www.wikidata.org/entity/Q36690983

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Experience and challenges from clinical trials with malaria vaccines in Africa

@ast

Experience and challenges from clinical trials with malaria vaccines in Africa

@en

type

label

Experience and challenges from clinical trials with malaria vaccines in Africa

@ast

Experience and challenges from clinical trials with malaria vaccines in Africa

@en

prefLabel

Experience and challenges from clinical trials with malaria vaccines in Africa

@ast

Experience and challenges from clinical trials with malaria vaccines in Africa

@en

P1433

Q36690983-51B2CE1C-ED8B-4F9D-96BC-FF49399B49F4

P1476

Q36690983-5D63396D-D4E9-4EB9-BEED-72691BDB2960

P2093

Q36690983-5A32A623-C4F6-40CC-8619-63765DE9F5FB

Q36690983-71CE3FF7-EF61-4E64-A47B-DC1774321373

Q36690983-7DACD44A-B0FA-4420-B000-6C330AEF22AB

Q36690983-9278DD73-E117-4CE1-BF79-76B8519FAEB3

Q36690983-9534BAD7-1FE3-48DA-B66D-E5339C73A981

Q36690983-E2D2D4D2-660D-4B7F-A6D1-CF93582C7F29

Q36690983-FDF52D8E-F07A-4B74-9E91-E39E7A204368

P275

Q36690983-3C629379-78EE-43E9-823C-2D22F4C9EE36

P2860

Q36690983-02DFF999-74E5-4B2A-B2AB-081FBC03824D

Q36690983-06610F5C-C53B-4620-930B-C7E8643C74A1

Q36690983-07D5894A-DDA0-4ED6-8A42-BA5D2F558A46

Q36690983-0990A14B-9137-4E69-8D77-6DC6DA7BECCD

Q36690983-0EF56754-EF2B-4102-A584-AB6A88527465

Q36690983-10B86EB0-3633-4F38-AADD-329888F4858C

Q36690983-134D53A3-F050-4C9E-B915-FD961DB0737A

Q36690983-16A3A6A1-02D1-4767-A3D4-D25A335D8F97

Q36690983-175E3F46-5FA1-4F9E-8414-CE8A5CF79877

Q36690983-1E19B04B-DB2D-47B7-B03E-2759CC51B190

P2888

Q36690983-C61E4732-787A-4E33-BF8A-78B3CA804098

P304

Q36690983-838CE8EB-7D4C-4C07-AF78-8A779EED1CE3

P31

Q36690983-2C734E8F-009C-4324-852F-C261CDAD2FA7

Q36690983-79B8CB3C-A447-423B-B220-8A38E1A2F59C

P356

Q36690983-296920B0-7354-4244-B6A9-91A38A6F83E3

P478

Q36690983-6FEFF6FD-F26D-4604-88E3-8FDB42FB87B8

P50

Q36690983-4FE7C6D4-3F13-4143-81BE-0F1669D6632F

Q36690983-6C53C7B9-C2AE-4BB6-BADE-1D3AE471BDDD

Q36690983-BFB81395-3DEA-498C-8FF3-E6D129C11285

P5008

Q36690983-2B29C6C0-34C5-436D-897F-7EBB85CFF5E7

P577

Q36690983-C7D28281-3FA4-4D2B-A6EC-B8D3A96B40BC

P5875

Q36690983-F8E61AC3-02D2-4C01-AC1D-B6F9F99E3C4D

P6179

Q36690983-A89556E8-4292-4719-A135-D3A31CC36E5B

P698

Q36690983-9F53B698-15EB-4E50-AC91-11032C77FFEA

P921

Q36690983-82A48119-A446-4629-BC53-E205B8449FFF

Q36690983-CFCC6A32-C8E5-4A46-B448-6E054422E37A

P932

Q36690983-140C9F1B-99E2-4D31-924D-CD1A96378B36

P356

1475-2875-12-86

P1433

Malaria Journal

P1476

Experience and challenges from clinical trials with malaria vaccines in Africa

@en

P2093

Beverly Msambichaka

http://www.w3.org/2001/XMLSchema#string

Grace Mwangoka

http://www.w3.org/2001/XMLSchema#string

Maxmillian Mpina

http://www.w3.org/2001/XMLSchema#string

Nahya Salim

http://www.w3.org/2001/XMLSchema#string

Seif Shekalaghe

http://www.w3.org/2001/XMLSchema#string

Shubis Kafuruki

http://www.w3.org/2001/XMLSchema#string

Tutu Mzee

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

A review of malaria vaccine clinical projects based on the WHO rainbow table

Grand challenges in global health: community engagement in research in developing countries

Challenges of establishing a Community Advisory Board (CAB) in a low-income, low-resource setting: experiences from Bagamoyo, Tanzania

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

The RTS,S malaria vaccine

Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria

Valid consent for genomic epidemiology in developing countries

Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.

P2888

1475-2875-12-86

P304

86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-12-86

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Bernhards Ogutu

P5008

P577

2013-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236051335

http://www.w3.org/2001/XMLSchema#string

P6179

1024690122

http://www.w3.org/2001/XMLSchema#string

P698

23496910

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

3599886

http://www.w3.org/2001/XMLSchema#string